Valeritas Holdings Inc (NASDAQ:VLRX) Shorted Shares Rose By 968.21%

June 27, 2018 - By Marcos Kline

It was noted an increase on Valeritas Holdings Inc (NASDAQ:VLRX)’s short interest with 968.21%. It was announced in June by FINRA the 161,300 short interest on VLRX. Previously was reported up change of 968.21% from 15,100 shares. Previous VLRX’s position will need 0 days to recover. It has 2.20M average volume. Valeritas Holdings Inc float short is 6.82%.

The stock decreased 4.00% or $0.06 during the last trading session, touching $1.44.Currently Valeritas Holdings, Inc. is downtrending after 68.29% change in last June 27, 2017. VLRX has also 561,423 shares volume. VLRX underperformed the S&P500 by 80.86%.

Valeritas Holdings, Inc., a commercial-stage medical technology company, focuses on developing technologies to treat patients with Type 2 diabetes.The firm is valued at $35.58 million. It offers V-Go, a disposable insulin delivery device for basal-bolus therapy.Currently it has negative earnings. The firm also develops h-Patch, a controlled delivery technology platform; Mini-Ject, a disposable needle-free injection system that delivers drugs ranging from small molecules to large proteins, as well as antibodies and vaccines; and Micro-Trans microneedle array patch technology to deliver drugs into the dermis layer of the skin.

For more Valeritas Holdings, Inc. (NASDAQ:VLRX) news brought out briefly go to: Benzinga.com, Streetinsider.com, Benzinga.com, Nasdaq.com or Benzinga.com. The titles are as follows: “44 Biggest Movers From Yesterday” brought out on June 26, 2018, “Pre-Open Movers 06/25: (XRM) (VLRX) (GTN) Higher; (SPHS) (MACK) (ATI) Lower (more…)” on June 25, 2018, “25 Stocks Moving In Monday’s Pre-Market Session” with a publish date: June 25, 2018, “Mid-Morning Market Update: Markets Open Lower; Carnival Cuts Profit Forecast” and the last “36 Stocks Moving In Monday’s Mid-Day Session” with publication date: June 25, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: